The rising prevalence in GLP-1 medications for metabolic conditions has generated a debate about formats: skin-applied devices versus capsules. Typically, GLP-1 therapies were exclusively available in https://miriamjydb294426.mpeblog.com/73867924/glp-1-transdermal-delivery-systems-vs-pills-is-suitable-for-the-patient